双重血浆置换联合甲氨蝶呤对类风湿性关节炎患者血清巨噬细胞集落刺激因子、血管内皮生长因子水平的影响

卢伟伟; 沈爱娟; 赵宁; 杨东星; 田俊阁

doi:10.14009/j.issn.1672-2124.2020.02.017

您当前的位置：

首页 >

文章列表页 >

双重血浆置换联合甲氨蝶呤对类风湿性关节炎患者血清巨噬细胞集落刺激因子、血管内皮生长因子水平的影响

论著 | 更新时间：2022-10-08

- 双重血浆置换联合甲氨蝶呤对类风湿性关节炎患者血清巨噬细胞集落刺激因子、血管内皮生长因子水平的影响
- Effect of Double Filtration Plasmapheresis Combined with Methotrexate on Serum Macrophage Colony Stimulating Factor and Vascular Endothelial Growth Factor in Patients with Rheumatoid Arthritis
- 中国医院用药评价与分析 2020年20卷第2期页码：194-196
- 作者机构：
  
  沧州中西医结合医院风湿一科
- 作者简介：
- 基金信息：
  
  沧州市重点研发计划指导项目（No.183302085）
- DOI：10.14009/j.issn.1672-2124.2020.02.017
  中图分类号： R593.22
- 纸质出版日期：2020，
扫描看全文
[1]卢伟伟,沈爱娟,赵宁,杨东星,田俊阁.双重血浆置换联合甲氨蝶呤对类风湿性关节炎患者血清巨噬细胞集落刺激因子、血管内皮生长因子水平的影响[J].中国医院用药评价与分析,2020,20(02):194-196+199.

LU Weiwei, SHEN Aijuan, ZHAO Ning, et al. Effect of Double Filtration Plasmapheresis Combined with Methotrexate on Serum Macrophage Colony Stimulating Factor and Vascular Endothelial Growth Factor in Patients with Rheumatoid Arthritis[J]. 2020,20(2):194-196.
[1]卢伟伟,沈爱娟,赵宁,杨东星,田俊阁.双重血浆置换联合甲氨蝶呤对类风湿性关节炎患者血清巨噬细胞集落刺激因子、血管内皮生长因子水平的影响[J].中国医院用药评价与分析,2020,20(02):194-196+199. DOI： 10.14009/j.issn.1672-2124.2020.02.017.

LU Weiwei, SHEN Aijuan, ZHAO Ning, et al. Effect of Double Filtration Plasmapheresis Combined with Methotrexate on Serum Macrophage Colony Stimulating Factor and Vascular Endothelial Growth Factor in Patients with Rheumatoid Arthritis[J]. 2020,20(2):194-196. DOI： 10.14009/j.issn.1672-2124.2020.02.017.

摘要

目的:探讨双重血浆置换联合甲氨蝶呤对类风湿性关节炎患者血清巨噬细胞集落刺激因子（M-CSF）及血管内皮生长因子（VEGF）的影响。方法:选取2017年1月至2018年12月沧州中西医结合医院收治的类风湿关节炎患者80例

随机分为研究组与对照组

每组40例。对照组患者给予甲氨蝶呤治疗

研究组患者在对照组的基础上给予双重滤过血浆置换治疗1次。观察两组患者治疗前后血清M-CSF、VEGF、炎症因子[肿瘤坏死因子α（TNF-α）、白细胞介素6（IL-6）和白细胞介素17（IL-17）]水平及症状评分情况

比较两组患者临床疗效及治疗期间不良反应发生情况的差异。结果:治疗后

两组患者M-CSF、VEGF、TNF-α、IL-6及IL-17水平均较治疗前明显降低

且研究组患者明显优于对照组

差异均有统计学意义（P<0. 05）。治疗后

两组患者压痛积分、晨僵时间、疼痛积分及肿胀积分均较治疗前明显改善

且研究组患者明显优于对照组

差异均有统计学意义（P<0. 05）。研究组患者的总有效率为82. 50%（33/40）

明显高于对照组的55. 00%（22/40）

差异有统计学意义（P<0. 05）。研究组、对照组患者的不良反应发生率分别为15. 00%（6/40）、10. 00%（4/40）

差异无统计学意义（P>0. 05）。结论:双重血浆置换联合甲氨蝶呤可降低类风湿关节炎患者体内的M-CSF、VEGF及炎症因子水平

减轻关节疼痛、肿胀和晨僵现象

疗效较好

安全性高。

Abstract

OBJECTIVE: To probe into the effects of double filtration plasmapheresis combined with methotrexate on serum macrophage colony stimulating factor（ M-CSF） and vascular endothelial growth factor（ VEGF） in patients with rheumatoid arthritis. METHODS: 80 patients with rheumatoid arthritis admitted into Cangzhou Hospital of Integrated TCM-WM from Jan. 2017 to Dec. 2018 were selected and randomly divided into research group and control group

with 40 cases in each group. The control group was treated with methotrexate

while the research group was given double filtration plasmapheresis once based on the control group. The serum M-CSF

VEGF

inflammatory factors [tumor necrosis factor-α（ TNF-α）

interleukin-6（ IL-6） and interleukin-17（ IL-17） ] levels and symptom scores of the two groups were observed before and after treatment. Differences in clinical efficacy and incidences of adverse drug reactions during treatment were compared between two groups. RESULTS: After treatment

the M-CSF

VEGF

TNF-α

IL-6 and IL-17 levels of both groups were significantly improved

and those of the research group were significantly better than the control group

with statistically significant differences（ P < 0. 05）. After treatment

the tenderness scores

morning stiffness

pain scores and swelling scores of two groups were significantly improved

and those of the research group were significantly better than the control group

with statistically significant differences（ P<0. 05）. The effective rate of research group was 82. 50%（ 33/40）

which was significantly higher than that of the control group（ 55. 00%

22/40）

with statistically significant difference（ P<0. 05）. The incidences of adverse drug reactions of research group and control group were respectively 15. 00%（ 6/40） and 10. 00%（ 4/40）

the difference had no statistical significance（ P > 0. 05）. CONCLUSIONS: The combination of double filtration plasmapheresis and methotrexate can reduce the M-CSF

VEGF and inflammatory factor levels in patients with rheumatoid arthritis

which can relieve arthralgia

arthrocele and morning stiffness

with remarkable efficacy and good safety.

关键词

双重血浆置换甲氨蝶呤M-CSFVEGF类风湿性关节炎

Keywords

Double filtration plasmapheresisMethotrexateMacrophage colony stimulating factorVascular endothelial growth factorRheumatoid arthritis

references

查看原文

浏览量

104

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

穴位贴敷辅助五味消毒饮对类风湿性关节炎患者免疫功能、Th17/Tregs平衡的影响

酪酸梭菌活菌散对大剂量甲氨蝶呤治疗的急性淋巴细胞白血病患儿免疫功能和化疗相关性腹泻的影响

甲氨蝶呤血药浓度和基因检测在治疗低危妊娠滋养细胞肿瘤中的价值研究

还原性叶酸载体1 G80A基因多态性与急性淋巴细胞白血病患儿使用大剂量甲氨蝶呤不良反应关系的系统评价

桂枝芍药知母汤联合甲氨蝶呤治疗活动期类风湿关节炎的疗效及影响因素分析